Comprehensive Evaluation and Future Perspectives of Non-Surgical Contraceptive Methods in Female Cats and Dogs
Authors:
- Sheila I. Peña-CoronaSPSheila I. Peña-Corona
- Melissa Aurea Vaquera-GuerreroMVMelissa Aurea Vaquera-Guerrero
- José Cerbón-GutiérrezJCJosé Cerbón-Gutiérrez
- Juan I. Chávez-CoronaJCJuan I. Chávez-Corona
- Adrián E. Iglesias-ReyesAIAdrián E. Iglesias-Reyes
- Alonso Sierra-ReséndizASAlonso Sierra-Reséndiz
- Juan José Pérez-RiveroJPJuan José Pérez-Rivero
- Socorro Retana-MárquezSRSocorro Retana-Márquez
- Pablo Adrián Vizcaino-DoradoPVPablo Adrián Vizcaino-Dorado
- David Quintanar-GuerreroDQDavid Quintanar-Guerrero
- Gerardo Leyva-GómezGerardo Leyva-Gómez
- Dinorah Vargas-EstradaDVDinorah Vargas-Estrada
Open Access
Abstract
The issue of stray cats and dogs is a global concern with considerable implications for animal welfare and public health. This review aims to provide an updated and comprehensive analysis of non-surgical contraceptive methods tested in studies controlled in vivo in feline and canine females. Immunocontraception via vaccination against gonadotropin-releasing hormone (GnRH), the luteinizing hormone receptor, zona pellucida proteins, and sperm, or use of viral-vectored delivery, is yet developing. Hormonal treatment (progestins, androgens, or GnRH) analogs act directly to block the reproductive axis. However, it produced essential side effects. Analogs of kisspeptin, non-steroid anti-inflammatory drugs such as firocoxib, and delivery of cytotoxins to the pituitary have shown non-conclusive results. Additional methods have also been tested, such as intraovarian injection of necrosing compounds or intravaginal and intrauterine devices. At present, neither of these methods offers permanent sterility that can replace surgical sterilization techniques. To our knowledge, none are currently authorized by the Food and Drug Administration (FDA) or the European Medicines Agency (EMA) for contraceptive methods or sterilization of cats or dogs. Therefore, it is necessary to continue the development of a compound that warrants the sterility of cats and dogs.Keywords
Funding Information
- DGAPA-UNAM (PAPIIT IN204722, PAPIME PE205524)
This publication has 98 references indexed in Scilit:
- Prostaglandin-mediated effects in early canine corpus luteum: In vivo effects on vascular and immune factorsReproductive Biology, 2019
- DNA Vaccine Targeting Gonadotropin-Releasing Hormone Receptor and Its Application in Animal ContraceptionMolecular Biotechnology, 2018
- Adeno-Associated Virus (AAV) as a Vector for Gene TherapyBioDrugs, 2017
- Ultrasonographic and histopathologic changes following injection of neutral zinc gluconate in dog’s ovariesComparative Clinical Pathology, 2017
- Transgenic mouse models to study Gpr54/kisspeptin physiologyPeptides, 2009
- New GnRH analogs in canine reproductionAnimal Reproduction Science, 2007
- Assessment of the immunological and biological efficacy of two different doses of a recombinant GnRH vaccine in domestic male and female cats (Felis catus)Journal of Reproductive Immunology, 2004
- Contraceptive potential of porcine zona pellucida in catsTheriogenology, 1995
- Normal Gonadal Functions and Fertility After 23 Months of Treatment of Prepubertal Male and Female Dogs with the GnRh Agonist [D‐Trp6, des‐Gly‐NH210]GnRH EthylamideJournal of Andrology, 1989
- Infertility in bitches induced by active immunization with porcine zonae pellucidaeJournal of Experimental Zoology, 1982